Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters

Orally administered small molecules may have important therapeutic potential in treating COVID-19 disease. The recently developed antiviral agents, Molnupiravir and Nirmatrelvir, have been reported to be efficient treatments, with only moderate side effects, especially when applied in the early phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakos, Éva, Temesszentandrási-Ambrus, Csilla, Özvegy-Laczka, Csilla, Gáborik, Zsuzsanna, Sarkadi, Balázs, Telbisz, Ágnes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379611/
https://www.ncbi.nlm.nih.gov/pubmed/37510996
http://dx.doi.org/10.3390/ijms241411237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379611/
https://www.ncbi.nlm.nih.gov/pubmed/37510996
http://dx.doi.org/10.3390/ijms241411237

Ejemplares similares